Deutsche Bank Upgrades Pediatrix Medical Group to Hold, Maintains Price Target to $8
Portfolio Pulse from Benzinga Newsdesk
Deutsche Bank has upgraded Pediatrix Medical Group (NYSE:MD) from Sell to Hold, while maintaining the price target at $8.
June 07, 2024 | 11:56 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Deutsche Bank has upgraded Pediatrix Medical Group from Sell to Hold, maintaining the price target at $8. This suggests a neutral outlook for the stock.
The upgrade from Sell to Hold indicates a more neutral stance from Deutsche Bank, suggesting that the stock may not see significant downside in the short term. However, maintaining the price target at $8 implies limited upside potential as well.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100